BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35873103)

  • 41. Targeting the Inducible T-cell Costimulator (ICOS) in Patients with Relapsed/Refractory T-follicular Helper Phenotype Peripheral T-cell and Angioimmunoblastic T-cell Lymphoma.
    Chavez JC; Foss FM; William BM; Brammer JE; Smith SM; Prica A; Zain JM; Tuscano JM; Shah H; Mehta-Shah N; Geethakumari PR; Wang BX; Zantinge S; Wang L; Zhang L; Boutrin A; Zhao W; Cheng L; Standifer N; Hewitt L; Enowtambong E; Shao W; Sharma S; Carlesso G; Moscow JA; Siu LL
    Clin Cancer Res; 2023 May; 29(10):1869-1878. PubMed ID: 36826995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary cutaneous follicular helper T-cell lymphoma: a new subtype of cutaneous T-cell lymphoma reported in a series of 5 cases.
    Battistella M; Beylot-Barry M; Bachelez H; Rivet J; Vergier B; Bagot M
    Arch Dermatol; 2012 Jul; 148(7):832-9. PubMed ID: 22508770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.
    de Leval L; Rickman DS; Thielen C; Reynies Ad; Huang YL; Delsol G; Lamant L; Leroy K; Brière J; Molina T; Berger F; Gisselbrecht C; Xerri L; Gaulard P
    Blood; 2007 Jun; 109(11):4952-63. PubMed ID: 17284527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary cutaneous follicular helper T-cell lymphoma.
    Santonja C; Soto C; Manso R; Requena L; Piris MA; Rodríguez-Pinilla SM
    J Cutan Pathol; 2016 Feb; 43(2):164-70. PubMed ID: 26282465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoclonal plasma cell infiltrates in the setting of cutaneous follicular helper T cell lymphoproliferative disorders.
    Magro CM; Ruan J; Grossman M; Hedayat AA
    Ann Diagn Pathol; 2019 Jun; 40():94-104. PubMed ID: 31077877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances.
    Lage LAPC; Culler HF; Reichert CO; da Siqueira SAC; Pereira J
    Front Oncol; 2023; 13():1177590. PubMed ID: 37182145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
    Timmins MA; Wagner SD; Ahearne MJ
    Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous lesions of angioimmunoblastic T-cell lymphoma: Clinical, pathological, and immunophenotypic features.
    Oishi N; Sartori-Valinotti JC; Bennani NN; Wada DA; He R; Cappel MA; Feldman AL
    J Cutan Pathol; 2019 Sep; 46(9):637-644. PubMed ID: 30980412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expressions of CXCL13, CD10 and bcl-6 in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified].
    Tang XF; Li GD; Li YL; Liang DN; Xia T; Zhou JY; Yao YQ; Wu WQ; Wang ZG; Yang YH; Tang XB; Bai YQ; Ding Q
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):224-30. PubMed ID: 19575892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
    Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
    Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis.
    Cortes JR; Ambesi-Impiombato A; Couronné L; Quinn SA; Kim CS; da Silva Almeida AC; West Z; Belver L; Martin MS; Scourzic L; Bhagat G; Bernard OA; Ferrando AA; Palomero T
    Cancer Cell; 2018 Feb; 33(2):259-273.e7. PubMed ID: 29398449
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Ioannidou K; Ndiaye DR; Noto A; Fenwick C; Fortis SP; Pantaleo G; Petrovas C; de Leval L
    Front Immunol; 2020; 11():607626. PubMed ID: 33633728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.
    Nicolae A; Pittaluga S; Venkataraman G; Vijnovich-Baron A; Xi L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2013 Jun; 37(6):816-26. PubMed ID: 23598959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of Master Regulators of T-cell, Helper T-cell and Follicular Helper T-cell Differentiation in Angioimmunoblastic T-cell Lymphoma.
    Matsumoto Y; Nagoshi H; Yoshida M; Kato S; Kuroda J; Shimura K; Kaneko H; Horiike S; Nakamura S; Taniwaki M
    Intern Med; 2017 Nov; 56(21):2851-2856. PubMed ID: 28943543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic Landscape of Peripheral T-Cell Lymphoma.
    Hathuc V; Kreisel F
    Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.
    Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK
    Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A suggested immunohistochemical algorithm for the classification of T-cell lymphomas involving lymph nodes.
    Vega F; Medeiros LJ
    Hum Pathol; 2020 Aug; 102():104-116. PubMed ID: 32479842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Follicular T-Helper Cells in Marginal Zone Lymphoma: Evidence of an Organoid Immune Response.
    Robson A; Bakr F; Rashidghamat E; Willsmore ZN; Ally M; Greenblatt D; Barlow R; Wain EM; Child F; Esdaile B; Kempf W
    Am J Dermatopathol; 2021 Dec; 43(12):e197-e203. PubMed ID: 34231493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD27/CD70 pathway activation in primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.
    Richter J; Oschlies I; Kock K; Wüseke T; Haag J; Koch K; Klapper W
    J Pathol; 2024 Feb; 262(2):189-197. PubMed ID: 37933684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers.
    Rodríguez Pinilla SM; Roncador G; Rodríguez-Peralto JL; Mollejo M; García JF; Montes-Moreno S; Camacho FI; Ortiz P; Limeres-González MA; Torres A; Campo E; Navarro-Conde P; Piris MA
    Am J Surg Pathol; 2009 Jan; 33(1):81-90. PubMed ID: 18987541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.